이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

3D Foot Scanning and Customized 3D-Printed Foot Orthotics to Reduce Pressure on the Feet of Healthy Adults

2026년 8월 19일 업데이트: Universitaire Ziekenhuizen KU Leuven

3D Surface Scanning for the Measurement of the Human Foot and Customized 3D Printed Foot Orthotics for Plantar Off-loading in Healthy Participants

The number of people with diabetes mellitus worldwide is increasing rapidly and is expected to rise to 439 million by 2030, or 7.7% of the total adult world population. The complications that can arise as a result of chronic diabetes represent a major problem in terms of clinical treatment, socio-economic consequences and costs to the health care system. One of the most serious complications is a diabetic foot, which is characterized by neuropathy, ischemia and limited joint mobility and makes the foot vulnerable to foot ulcers and possible amputation. Various interventions are being investigated to prevent foot ulcers, including custom-made foot orthotics (CFOs), also known as foot orthoses. The latter allows the health professional to achieve a number of functional effects, of which the redistribution of the plantar pressure load is the most valuable, especially in patients with so-called risk feet.

The use of integrated computer-aided design and computer-aided manufacturing systems to produce CFOs has become increasingly popular over the past decade. In practice, this digital workflow comprises three different phases. First the (3D) foot shape of the patient is recorded, then the arch support is designed using special software and finally the device is made using a subtractive or additive manufacturing process (3D printing). As a result, it can be concluded that the first two phases are decisive for determining the geometric characteristics of a CFO, while the last phase is more critical for selecting the material properties.

As for the first phase, digital approaches were developed, such as 3D optical scanning that allows the researcher to scan body parts directly, providing a robust base for determining a CFO's geometrical features. The anthropometric foot parameters examined were worth investigating, but exclusively zero-dimensional in nature, providing limited insight when assessing the 3D fit of a custom made foot orthotic. Thus, current knowledge in this area remains scarce and further efforts are needed to better understand the role of 'geometrical features' in dose-response characteristics of custom orthotics.

With regard to the production phase, additive manufacturing or 3D printing is gaining more and more attention and could potentially set a new standard for manufacturing CFOs. Limited research shows that 3D printed CFOs can be used to reduce plantar pressure in healthy and diabetic populations. However, it is important to mention that these studies have not fully exploited the possible complex design options that the additive manufacturing process can provide, as their designs are very similar to those used in less polyvalent subtractive manufacturing processes. In addition, the relief properties of previously described CFOs are not or rarely driven by patient-specific plantar pressure data.

Research design Prospective monocentric observational study with a healthy, asymptomatic population.

Objectives The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults.

The study consists of two parts:

  • Reliability study
  • Observational study

Reliability study The methodological part of the current study consists of a reliability study with the focus on scanning the human foot. Since capturing the foot shape is the first step in the manufacturing process of custom insoles, it is important to use a reliable and objective scanning technique. This study aims to test the reliability, more specifically the intra-, inter-rater and test-retest reliability, of a portable, optical 3D scanner. In addition to the traditional zero-dimensional anthropometric measurements of the foot, mainly one-dimensional outcome measures will be studied.

Observational study In the observational part, the pressure distribution mechanism of several 3D-printed CFOs on the plantar pressure in asymptomatic patients with a so-called M2-M3 (metatarsal head of the second and third toe) pressure pattern at the level of the forefoot. There is a limited amount of literature on the effect of custom 3D-printed foot orthotics on plantar pressure distribution in healthy populations. In addition, the currently available literature appears to contain heterogeneous groups of participants with different plantar pressure distribution patterns, which complicates correct interpretation and generalization of the results, as the same orthosis designs are used for different pressure distribution patterns. During this study, several custom 3D-printed insoles, differentiated in padding density, structural architecture and geometric shape, will be applied to participants with M2-M3 forefoot patterns and then documented with a pressure distribution alg. Finally, a durability study will be conducted with the custom sole that provides the best relief from the peak pressure area of the forefoot.

연구 개요

상태

완전한

정황

개입 / 치료

연구 유형

중재적

등록 (실제)

33

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • West-Flanders
      • Bruges, West-Flanders, 벨기에, 8200
        • KU Leuven Campus Bruges

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

예

설명

Reliability study:

The inclusion criteria:

• Healthy population, age 18-65-year-old

The exclusion criteria:

  • No injury of trauma of the lower limb in the past 6 months
  • No surgical procedures of the lower limbs or back in the past 6 months
  • Not pregnant at the time of testing
  • No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
  • No systemic or neurological disorder

Interventional study

The inclusion criteria:

  • Healthy population, age 18-65-year-old
  • Maximum weight of 90 kg
  • In-shoe M2 - M3 or central pattern bilateral or left/right

The exclusion criteria:

  • No injury of trauma of the lower limb in the past 6 months
  • No surgical procedures of the lower limbs or back in the past 6 months
  • Not pregnant at the time of testing
  • No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
  • No systemic or neurological disorder
  • Work does not require wearing safety shoes

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Within-Participant Orthotic Comparison
The study still has one experimental arm; the different orthoses are intervention conditions within that arm. It is a single-group, within-participant repeated-measures design.
Foot orthotics

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Effect of custom-made foot orthotics on plantar pressure in people with a M2-3 pressure pattern.
기간: From enrollment to the end of the of the test at 6 weeks.
The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults with a M2-3 pressure pattern.
From enrollment to the end of the of the test at 6 weeks.
Reliability of 3D scanning
기간: From enrollment to final scanning after 3 days.
To evaluate the inter-, intra-rater and test-retest reliability of 3D surface scanning for measuring and recording human foot shape in a non-weight bearing condition.
From enrollment to final scanning after 3 days.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2023년 10월 23일

기본 완료 (실제)

2026년 6월 4일

연구 완료 (실제)

2026년 8월 19일

연구 등록 날짜

최초 제출

2026년 8월 19일

QC 기준을 충족하는 최초 제출

2026년 8월 19일

처음 게시됨 (실제)

2026년 8월 24일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 8월 24일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 8월 19일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • S67786

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다